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responsibility of XAbstract A simple, speciﬁc, precise, sensitive and rapid reverse phase-HPLC method was developed
for determination of ketorolac enantiomers, a potent nonnarcotic analgesic in pharmaceutical
formulations. The method was developed on a chiral AGP column. Mobile phase was 0.1 M sodium
phosphate buffer (pH 4.5): Isopropanol (98:2, v/v), at a ﬂow rate of 1 mL/min with run time of
15 min. Ultraviolet detection was made at 322 nm. The linearity range was 0.02–10 mg/mL for each of
the enantiomers. The mobile phase composition was systematically studied to ﬁnd the optimum
chromatographic conditions. Validation of the method under the conditions selected showed that it
was selective and precise and that the detector response was linear function of ketorolac.
& 2012 Xi’an Jiaotong University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Ketorolac tromethamine is a pyrrolizine carboxylic acid deri-
vative used for its analgesic activity [1], with cyclooxygenase
inhibitory activity. It is approved for the treatment of mild to
moderately severe post-operative pain. The drug is available as
a racemic mixture of an equimolar ratio of R (þ) and S ()ersity. Production and hosting by E
.006
7146578.
om (S.K. Dubey)
i’an Jiaotong University.stereoisomers (Fig. 1) [2]. Enantiomers of chiral drugs can
present differences in pharmacological activity or efﬁcacy.
Enantioselective analytical techniques have therefore become
more and more important in the ﬁeld of drug analysis.
Enantiomeric separations of ketorolac were performed by
liquid chromatography (LC), using an indirect method; with
nonchiral stationary phases [3–6]. Chiral stationary phases for
the separation of the enantiomers are made of immobilized
proteins such as human serum albumin [7], a1-acid glycoprotein
[8,9], or amylose tris (3, 5-dimethylphenylcarbamate) [10]. The
methods reported for chiral separation of ketorolac have either
long analysis time or are less sensitive [11]. The aim of this
study was to develop a simple, speciﬁc, sensitive and precise
reverse phase chiral high performance liquid chromatographic
method for determination of ketorolac enantiomers (Fig. 1) inlsevier B.V. All rights reserved.
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glycoprotein (AGP) column with photo diode array (PDA)
detector.Table 1 Effect of pH on selectivity, resolution and
capacity factor.2. Materials and methods
2.1. Chemicals
Ketorolac enantiomers were purchased from TRC, Canada.
Methanol (MeOH), isopropanol (IPA), and acetonitrile (ACN)
used were procured from Merck, India. Sodium di-hydrogen
phosphate (NaH2PO4), sodium hydroxide and phosphoric acid
of AR grade were also obtained from Merck, India.
2.2. Instrumentation
Quantitative reverse phase high performance liquid chromato-
graphy (RP-HPLC) was performed on isocratic ultra fast
liquid chromatography (Shimadzu) with PDA detector. The
column used was chiral-AGP column (100 mm 4.0 mm I.D.,
particle size 5 mm, Chrom Tech Ltd., Sweden). AG-135
analytical electronic balance and pH meter were from MET-
TLER-TOLEDO and EUTECH respectively.
2.3. HPLC conditions and chiral column
Mobile phase was ﬁltered before use through a 0.22 mm mem-
brane ﬁlter. Then it was degassed in a bath sonicator for 20 min
and pumped from the solvent reservoir to the column at a ﬂow
rate of 1 mL/min to equilibrate the system. Injection volume
was optimized to 50 mL. The back pressure yielded was 735.49–
931.63 Kg m/s2. The run time was set for 15 min and eluents
were monitored at 322 nm. The column used was made of
AGP, a glycoprotein containing 183 amino acids and carbohy-
drate moiety in the form of N-linked glycans [12], having
isoelectric point of 2.7–3.8 [13]. The carbohydrate moiety is
believed to be involved in binding of compounds. The enantio-
selective properties of chiral-AGP may be affected by several
chromatographic parameters such as the buffer nature, the
pH value of the buffer, the organic modiﬁer (nature and
percentage), the buffer concentration, the presence of charged
additives in the mobile phase and the temperature [14].
2.4. Preparation of sample and method development
Sodium dihydrogen phosphate 0.1 M was used in the mobile
phase. The optimized pH of the mobile phase was developed
by working in the range of 4–7. Different organic modiﬁers,
namely, isopropanol, acetonitrile and methanol were used and
the one which gave better results was used in concentration
range of 2–10% of mobile phase. The order of elution was
determined based on their retention time by separatelyFigure 1 Chemical structure of ketorolac enantiomers.injecting pure enantiomers of ketorolac. Primary stock solu-
tion of 100 mg/mL ketorolac racemic mixture was prepared by
dissolving 5 mg of racemic ketorolac in a 50 mL volumetric
ﬂask containing methanol and the volume was made by
methanol. Working standard solutions were prepared by
suitable dilution of primary stock solutions with mobile phase.2.5. Method validation
2.5.1. Calibration curve
It was obtained by preparing three sets of the drug solutions in
mobile phase containing ketorolac racemates at a concentra-
tion of 20 ng/mL–10 mg/mL; 50 mL of these drug solutions
were injected into column, and the peak area and retention
time were recorded. The regression curve was constructed by
plotting the peak areas against the concentration of racemates
in mg/mL.2.5.2. Precision and accuracy
Minimum of nine determinations was done over three con-
centration levels in triplicate [15]. Percentage relative standard
deviation (% RSD) of peak area and the percentage of bias
were calculated for precision and accuracy, respectively.2.5.3. Limits of detection (LOD) and quantiﬁcation (LOQ)
LOD and LOQ were calculated on the basis of response and
slope of the regression equation. They were calculated from
the formula 3.3s/S and 10s/S respectively where ‘s’ is
standard deviation of the y-intercept of the regression line
and ‘S’ is slope of the calibration curve.2.5.4. Solution stability
Stability of drug solution was studied by keeping the solution
in a tightly closed volumetric ﬂask in the refrigerator for 48 h.
Content of each enantiomer was checked at regular intervals
up to the study period.3. Results and discussion
The variables which altered the enantioselectivity when using
chiral AGP column were chosen and the effect of each variable
was studied. The variables selected were pH of buffer, organic
modiﬁer and organic modiﬁer concentration. Here, the effect
of individual variable was studied by keeping all other chro-
matographic conditions constant.Mobile phase a Rs k k
1
95:5 (0.1 M NaH2PO4,pH 4 :IPA) 1.3 1.9 3.6 4.7
95:5 (0.1 M NaH2PO4,pH 4.5 :IPA) 1.4 1.8 3.5 4.8
95:5 (0.1 M NaH2PO4,pH 5.5 :IPA) 2.0 1.8 0.5 0.9
a—Selectivity; Rs—Resolution; k—Capacity factor for
R-enantiomer; k1—Capacity factor for S-enantiomer;
IPA—Isopropanol.
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3.1.1. Effect of pH
Increase in the pH increased the negative charge on column.
Retention of ketorolac, decreases, and it elutes much faster,
which means decreased value of capacity factor as shownTable 2 Effect of organic modiﬁer on selectivity, resolu-
tion and capacity factor.
Mobile phase a Rs k k
1
95:5 (0.1 M NaH2PO4,pH 4.5:IPA) 1.4 1.8 3.5 4.8
95:5 (0.1 M NaH2PO4,pH 4.5:MeOH) 1.3 1.4 6.1 7.6
95:5 (0.1 M NaH2PO4,pH 4.5:ACN) 1.2 1.3 6.6 8.0
a—Selectivity; Rs—Resolution; k—Capacity factor for
R-enantiomer; k1—Capacity factor for S-enantiomer; IPA—I-
sopropanol; MeOH—Methanol; ACN—Acetonitrile.
Table 3 Effect of organic modiﬁer concentration on resolu-
tion and capacity factor.
Mobile phase Rs k k
1
98:2 (0.1 M NaH2PO4,pH 4.5:IPA) 2.3 5.1 6.1
95:5 (0.1 M NaH2PO4,pH 4.5:IPA) 1.8 3.5 4.8
Rs—Resolution; k—Capacity factor for R-enantiomer;
k1—Capacity factor for S-enantiomer; IPA—Isopropanol.
Table 4 Validation parameters of each enantiomer.
Concentration of each enantiomer
(mg/mL)
Repeatability (n¼3,
% RSD)
R-Ketorolac S-Ketorolac
0.05 1.7 1.9
5.00 1.4 1.0
10.00 0.7 1.1
RSD: Relative standard deviation.
Figure 2 Chromatogram of 3 mg/mL of racemic ketorolac show-
ing the two completely resolved peaks of R and S enantiomers.
Mobile phase: 98:2 (0.1 M NaH2PO4, pH 4.5 :IPA), ﬂow rate
1 mL/min.in Table 1. The opposite thing occurred by decreasing the pH.
Optimized pH was found to be 4.5 by several trails.
3.1.2. Effect of organic modiﬁer
The use of organic modiﬁer also played a major role. IPA gave
optimized values of resolution, selectivity and capacity factor
as shown in Table 2.
3.1.3. Effect of organic modiﬁer concentration
The maximum amount of organic modiﬁer to be used was
20% of mobile phase, as the concentration increased the
resolution and the retention time decreased. Optimized ratio
was found to be 98:2 (buffer: IPA) as it gave better resolution,
as shown in Table 3.
3.2. Method validation
The optimized mobile phase was found to be 98:2 (0.1 M
NaH2PO4, pH 4.5: IPA). The order of elution was, that R (þ)
enantiomer eluted faster than S () enantiomer and their
retention times was 6.4 and 8.4 min respectively (Fig. 2). During
development of the method on the chiral AGP column, it was
shown that the method was selective because the enantiomers
were separated to baseline (RS¼2.3). The validation parameters
of the optimized method are given in Table 4, the linearity
range of each enantiomer solution of ketorolac was found to be
20 ng/mL–10 mg/mL and the LOD and LOQ values for each
enantiomer was found to be 5 ng/mL and 15 ng/mL, respec-
tively. The RSD for repeatability (within-day precision, n¼3)
and RSD for reproducibility (between-day precision, n¼3) for
each enantiomer at three different quantiﬁcation concentrations
were found to be less than 2%. These results conﬁrmed the
good precision of the method and the % bias less than 2% at
each concentration (n¼3) indicated that the method was
accurate. The correlation coefﬁcients for the relationships
between concentration and detector response showed that the
response was linear in the range examined. By changing the
ﬂow rate there was a change in retention time only but the
resolution and selectivity were not signiﬁcantly affected. There-
fore, the method was robust and there was no signiﬁcant
change in the content of enantiomers after 48 h. So, the drug
solution was stable for 48 h.4. Conclusion
A simple reversed-phase HPLC method for analysis of the
enantiomers of ketorolac has been developed and validated.Intermediate precision (n¼3,
% RSD)
Accuracy (n¼3, % bias)
R-Ketorolac S-Ketorolac R-Ketorolac S-Ketorolac
1.9 1.9 1.3 1.8
1.6 1.8 1.5 1.7
1.0 1.4 1.0 1.2
New chiral reverse phase HPLC method for enantioselective analysis of ketorolac using chiral AGP column 465Use of chiral AGP and the approach to optimize the chro-
matographic conditions in order to obtain better resolution,
selectivity and reduced time of analysis were described by
studying the effect of each variable. The optimized chromato-
graphic conditions gave baseline separation with resolution
of approximately 2.2 for the enantiomers within 10 min. The
method is linear, precise, accurate and sensitive, thus being
suitable for daily direct enantioselective analysis of ketorolac.
The method is also very robust and enables quality-control
analysis of enantiomer composition and purity with large
sample throughput.
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